Loading...
XNYSIGC
Market cap18mUSD
Jan 10, Last price  
0.35USD
1D
4.12%
1Q
-5.51%
Jan 2017
23.21%
IPO
-99.40%
Name

IGC Pharma Inc

Chart & Performance

D1W1MN
XNYS:IGC chart
P/E
P/S
13.61
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
10.70%
Rev. gr., 5y
-23.45%
Revenues
1m
+47.64%
210,584-765,0472,188,00035,338,72517,897,8264,073,9194,199,5518,030,0162,273,1557,680,2576,366,550580,3722,192,5905,116,0004,072,000898,000397,000911,0001,345,000
Net income
-13m
L+13.63%
91,9011,517,997-5,215,000-521,576-4,789,311-20,240,907-7,751,925-2,252,347-3,022,593-4,614,183-2,808,244-1,867,260-1,786,274-4,097,000-8,097,000-8,980,000-14,604,000-11,441,000-13,000,000
CFO
-5m
L-26.22%
-95,208-1,558,559-8,569,000-8,113,641-2,955,461-2,634,736-5,022,362178,199-1,742,054-2,583,642-157,702-1,391,077-1,931,078-3,330,000-8,677,000-10,800,000-7,462,000-7,047,000-5,199,000
Earnings
Feb 12, 2025

Profile

India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
IPO date
Apr 13, 2006
Employees
61
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,345
47.64%
911
129.47%
397
-55.79%
Cost of revenue
4,385
3,930
2,533
Unusual Expense (Income)
NOPBT
(3,040)
(3,019)
(2,136)
NOPBT Margin
Operating Taxes
(65)
(412)
Tax Rate
NOPAT
(3,040)
(2,954)
(1,724)
Net income
(13,000)
13.63%
(11,441)
-21.66%
(14,604)
62.63%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,527
103
4,145
BB yield
-14.99%
-0.58%
-8.74%
Debt
Debt current
124
133
3
Long-term debt
429
688
826
Deferred revenue
Other long-term liabilities
20
21
16
Net debt
(645)
(3,480)
(9,999)
Cash flow
Cash from operating activities
(5,199)
(7,047)
(7,462)
CAPEX
(138)
(619)
(742)
Cash from investing activities
(317)
(235)
(742)
Cash from financing activities
3,524
100
4,142
FCF
1,905
(74)
3,047
Balance
Cash
1,198
3,350
10,460
Long term investments
951
368
Excess cash
1,131
4,255
10,808
Stockholders' equity
7,321
14,911
23,892
Invested Capital
6,555
10,281
13,588
ROIC
ROCE
EV
Common stock shares outstanding
58,840
52,576
49,992
Price
0.40
17.82%
0.34
-64.22%
0.95
-46.99%
Market cap
23,536
31.86%
17,850
-62.37%
47,437
-36.85%
EV
22,891
14,370
37,438
EBITDA
(2,403)
(2,362)
(1,485)
EV/EBITDA
Interest
412
Interest/NOPBT